Key facts
- It has raised $5.0M; the latest was Later Stage VC ($2.7M) in Dec 2025.
- Notable investors include Augebit FIZ, Quercus TFI, iif.vc, the Manawa Family Foundation.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for BioResearch Pharma
- ·The full record, as it builds
Funding rounds
No funding rounds for BioResearch Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BioResearch Pharma
Developer of dermatological therapies designed to create topical dermatology treatments. The company offers therapies for androgenetic alopecia, plaque psoriasis, alopecia areata, atopic dermatitis, and more, enabling healthcare professionals to treat skin diseases and enhance patients' hair growth.
- Sector
- Healthcare
- HQ
- Warsaw, Poland
- Founded
- 2021
- Website
- bioresearchpharma.com/
- Ownership
- Privately Held (backing)
BioResearch Pharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioResearch Pharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioResearch Pharma in its N-PORT filings yet. We sweep new filings monthly.